end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsFairValueDisclosure,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ContractWithCustomerLiability,ConversionOfStockAmountConverted1,ConvertiblePreferredDividendsNetOfTax,ConvertiblePreferredStockSharesIssuedUponConversion,CurrentFederalStateAndLocalTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredOfferingCosts,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,Depreciation,DepreciationNonproduction,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings,GainLossOnSaleOfPropertyPlantEquipment,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,IncomeTaxExpenseBenefit,IncomeTaxesPaidNet,IncomeTaxesReceivable,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInDeferredCharges,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpenseDebt,InterestIncomeExpenseNonoperatingNet,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NetIncomeLossAvailableToCommonStockholdersDiluted,NoninterestExpenseOfferingCost,NonoperatingIncomeExpense,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAssetsCurrent,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,PaymentsOfFinancingCosts,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockDividendsIncomeStatementImpact,PreferredStockSharesAuthorized,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,PrepaidRent,ProceedsFromIncomeTaxRefunds,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromStockOptionsExercised,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCash,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SaleOfStockConsiderationReceivedOnTransaction,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,ShortTermLeaseCost,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures,StockIssuedDuringPeriodValueStockOptionsExercised,TaxesPayableCurrent,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,TemporaryEquityStockIssuedDuringPeriodValueNewIssues,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,OtherAssetsNoncurrent
2020-03-31,2020-05-22,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,2426000.0,,6022000.0,1034000.0,,6674000.0,12000.0,,12000.0,11858708.0,60592000.0,58539000.0,,54518000.0,,54633000.0,47498000.0,11858708.0,0.0001,35000000.0,2491670.0,2491670.0,1000.0,,,806000.0,10725129.0,,,,2019000.0,,,,,,,,,,,63000.0,,,-5.11,,,,,,,,,,396000.0,,1000.0,100000.0,-1490000.0,,1977000.0,,-12064000.0,,,-172000.0,,172000.0,-193000.0,,3271000.0,0.0,156000.0,,-15000.0,816000.0,2000.0,,,,,,,,9737000.0,60592000.0,8836000.0,55794000.0,-176000.0,-8120000.0,-11892000.0,-12698000.0,,,-1560000.0,,10504000.0,-10504000.0,,,388000.0,797000.0,,1116000.0,89000.0,,335000.0,226000.0,104000.0,-68000.0,,219000.0,176000.0,806000.0,,,1197000.0,,0.0,,,,56000000.0,13000.0,,822000.0,8527000.0,115000.0,115000.0,-31542000.0,0.0,,,12000.0,,602434.0,0.3,321000.0,3030.0,,0.0,49.15,7935000.0,1116301.0,0.36,0.28,0.16,,,4319000.0,,,-24867000.0,44686.0,,,0.0,13000.0,43000.0,75722000.0,82844000.0,26339678.0,10725129.0,10725129.0,0.0,,,,2484057.0,,,,,,
2020-06-30,2020-08-13,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,4852000.0,,3042000.0,125000.0,,183658000.0,1139000.0,8000.0,1139000.0,,150438000.0,148517000.0,,144687000.0,,144802000.0,,2482902.0,0.0001,200000000.0,20158080.0,20158080.0,2000.0,,,206000.0,,,,,0.0,,,,,,,,,,,,,-0.62,-0.62,-0.62,,,,,,,,,855000.0,,0.0,18800000.0,0.0,,3650000.0,,-10757000.0,,,0.0,,172000.0,,,,,,,,,1000.0,,,,,,,,9077000.0,150438000.0,8294000.0,,,,-10757000.0,-10963000.0,-10963000.0,8000.0,157000.0,,10914000.0,-10914000.0,,,400000.0,692000.0,,1025000.0,,,279000.0,422000.0,91000.0,158000.0,,,,206000.0,,0.0,3830000.0,2296000.0,0.0,,,,,,,781000.0,7264000.0,115000.0,115000.0,-42299000.0,0.0,,,,,636577.0,0.4,,,,,,67384000.0,2482902.0,10.37,,,,,23625000.0,,,141361000.0,,75722000.0,100123000.0,0.0,9000.0,0.0,,,,,,,,,17623994.0,17623994.0,17623994.0,,,,,
2020-09-30,2020-11-10,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,1716000.0,,4697000.0,206000.0,,185091000.0,1424000.0,,1424000.0,,138246000.0,136416000.0,,133810000.0,,133925000.0,,2484152.0,0.0001,200000000.0,20185730.0,20185730.0,2000.0,,,0.0,,,,,0.0,,,,,,,,,,,,,-0.6,-0.6,-0.6,,,,,,,,,1209000.0,,0.0,18500000.0,0.0,,3553000.0,,-12036000.0,,,0.0,,172000.0,,,,,,,,,2000.0,,116000.0,,,,,,7488000.0,138246000.0,6825000.0,,,,-12036000.0,-12036000.0,-12036000.0,,-88000.0,,11948000.0,-11948000.0,116000.0,,412000.0,586000.0,,976000.0,,0.0802,130000.0,440000.0,77000.0,-86000.0,,,,0.0,,0.0,2606000.0,1543000.0,0.0,,,,,,,739000.0,8395000.0,115000.0,115000.0,-54335000.0,0.0,,,,,694023.0,0.49,,,,,,68959000.0,2484152.0,10.95,,,,,26436000.0,,,130758000.0,,,,0.0,9000.0,0.0,,,,,,,,0.0,20175883.0,20175883.0,20175883.0,,,,,
2020-12-31,2021-03-25,10-K,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,2149000.0,0.0,4612000.0,265000.0,721000.0,326730000.0,4097000.0,,4097000.0,2499603.0,269443000.0,267726000.0,0.0,265876000.0,262000000.0,265991000.0,258856000.0,2499603.0,0.0001,200000000.0,23192866.0,23192866.0,2000.0,,75714000.0,,,-172000.0,-172000.0,0.0,0.0,139000.0,18187000.0,0.0,249000.0,10324000.0,4319000.0,2766000.0,639000.0,17938000.0,249000.0,278000.0,300000.0,-2.93,-2.93,-2.93,0.004,0.21,-0.264,-0.003,-0.003,0.02,0.047,-0.015,1510000.0,18700000.0,0.0,,-1490000.0,0.0,12797000.0,-31898000.0,-45533000.0,-13635000.0,-45533000.0,-172000.0,0.0,172000.0,61000.0,0.0,2590000.0,0.0,-604000.0,-376000.0,-57000.0,1469000.0,6000.0,-6000.0,468000.0,979000.0,482000.0,497000.0,,80000.0,7722000.0,269443000.0,7184000.0,296044000.0,-294000.0,-36894000.0,-45361000.0,-45361000.0,-45361000.0,,1124000.0,1.0,46657000.0,-46657000.0,468000.0,899000.0,423000.0,476000.0,468000.0,878000.0,327000.0,0.0802,160000.0,218000.0,62000.0,160000.0,420000.0,227000.0,294000.0,0.0,,0.0,1850000.0,785000.0,0.0,,102672000.0,140530000.0,56000000.0,38000.0,1445000.0,724000.0,33860000.0,115000.0,115000.0,-65011000.0,0.0,44000.0,,4097000.0,,723130.0,0.57,3349000.0,,3030.0,1452091.0,15.57,147103000.0,2499603.0,11.77,0.34,,0.16,20.0,50599000.0,200000.0,36290.0,261721000.0,113475.0,75722000.0,,0.0,38000.0,185000.0,,,,,,-8000.0,12000000.0,,15506397.0,15506397.0,15506397.0,-172000.0,0.0,0.0,-0.011,0.0
2021-03-31,2021-05-06,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,3008000.0,,5506000.0,352000.0,,329266000.0,2494000.0,,2494000.0,2801491.0,257730000.0,255982000.0,,255203000.0,,255318000.0,-10673000.0,,0.0001,200000000.0,23271494.0,23271494.0,2000.0,,,,,,,,,,,,,,,,,,,80000.0,,,-0.68,,,,,,,,,,636000.0,,0.0,35700000.0,0.0,,4274000.0,,-15835000.0,,,50000.0,,0.0,859000.0,,894000.0,0.0,0.0,,-15000.0,-1071000.0,1000.0,,,,,,,,9358000.0,257730000.0,8950000.0,42000.0,-210000.0,-10505000.0,-15885000.0,-15885000.0,,,-66000.0,,15769000.0,-15769000.0,,,436000.0,361000.0,,779000.0,99000.0,,265000.0,207000.0,47000.0,-65000.0,,0.0,210000.0,0.0,,0.0,779000.0,34000.0,,,,,0.0,42000.0,,854000.0,11495000.0,115000.0,115000.0,-80896000.0,,,,2494000.0,,969472.0,5.23,5059000.0,26734.0,,407250.0,49.15,118985000.0,2801491.0,20.44,0.53,24.56,,70.1,54632000.0,3700000.0,,248372000.0,78628.0,,,,42000.0,140000.0,,,,,,,,,,23229794.0,,,,,,
2021-06-30,2021-08-05,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,1372000.0,100000.0,5710000.0,697000.0,,332172000.0,2849000.0,,2849000.0,,243461000.0,241417000.0,,237113000.0,,237228000.0,,,0.0001,200000000.0,23328771.0,23328771.0,2000.0,,,,,,,,,,,,,,,,,,,,,-0.67,,-0.67,,,,,,,,,1168000.0,,,35600000.0,0.0,,5658000.0,,-15622000.0,,,0.0,,0.0,,,,,,,,,1000.0,,,,,,,,7805000.0,243461000.0,7531000.0,,,,-15622000.0,-15622000.0,-15622000.0,,-81000.0,,15641000.0,-15541000.0,,,449000.0,242000.0,,676000.0,,,290000.0,672000.0,32000.0,-80000.0,,,,0.0,,,4204000.0,2722000.0,,,,,,,,1253000.0,9983000.0,115000.0,115000.0,-96518000.0,100000.0,,,,,1080101.0,7.36,,,,,,71592000.0,2820472.0,21.73,,,,,38047000.0,,,235656000.0,,,,,57000.0,106000.0,,,,,,,,,23305673.0,,23305673.0,,,,,
2021-09-30,2021-11-04,10-Q,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,2811000.0,,7361000.0,657000.0,,335291000.0,3084000.0,,3084000.0,,229962000.0,226074000.0,,221349000.0,,222677000.0,,,0.0001,200000000.0,23396793.0,23396793.0,2000.0,,,,,,,,,,,,,,,,,,,,,-0.87,,-0.87,,,,,,,,,1765000.0,,,32900000.0,0.0,,5365000.0,,-20335000.0,,,-38000.0,,24000.0,,,,,,,,,1000.0,,120000.0,1372000.0,913000.0,233000.0,226000.0,76000.0,11484000.0,229962000.0,11015000.0,,,,-20297000.0,-20297000.0,-20297000.0,,-138000.0,,20197000.0,-20197000.0,120000.0,1296000.0,843000.0,453000.0,,1265000.0,,0.0727,313000.0,202000.0,16000.0,-137000.0,,,,0.0,,,4725000.0,1854000.0,66000.0,,,,,,,1295000.0,14832000.0,1328000.0,1328000.0,-116815000.0,0.0,,,,,1152714.0,9.13,,,,,,59493000.0,2724800.0,22.53,,,,,35472000.0,,,218478000.0,,,,,35000.0,83000.0,,,,,,,,0.0,23362237.0,,23362237.0,,,,,
2021-12-31,2022-03-09,10-K,"KEROS THERAPEUTICS, INC.",KROS,CIK0001664710,USD,3645000.0,18000000.0,7339000.0,532000.0,846000.0,366927000.0,11722000.0,,11722000.0,2810684.0,255251000.0,251440000.0,11000.0,230042000.0,230000000.0,231369000.0,-34622000.0,2810684.0,0.0001,200000000.0,23974834.0,23974834.0,2000.0,,0.0,,,,2011000.0,0.0,,127000.0,35728000.0,0.0,283000.0,23723000.0,4668000.0,6315000.0,895000.0,35445000.0,283000.0,378000.0,400000.0,-2.52,,-2.52,-0.035,0.21,-0.309,0.0,-0.003,-0.006,0.067,-0.048,2373000.0,35300000.0,0.0,,0.0,-46000.0,21330000.0,-55961000.0,-56733000.0,-772000.0,,2011000.0,,30000.0,1485000.0,18000000.0,2652000.0,,0.0,-597000.0,-62000.0,1548000.0,4000.0,,587000.0,1147000.0,913000.0,234000.0,,54000.0,12077000.0,255251000.0,11846000.0,28550000.0,-1024000.0,-62148000.0,-58744000.0,-58744000.0,-58744000.0,,-360000.0,1.0,76473000.0,-56373000.0,587000.0,1093000.0,862000.0,231000.0,587000.0,1067000.0,520000.0,0.0727,340000.0,204000.0,0.0,-356000.0,0.0,,1024000.0,,,0.0,3398000.0,993000.0,,,0.0,,0.0,379000.0,2181000.0,1335000.0,55143000.0,1327000.0,1327000.0,-123755000.0,20100000.0,,,11722000.0,,1223019.0,10.48,13276000.0,1375.0,175984.0,750408.0,42.29,11383000.0,2810684.0,24.62,1.45,50.77,28.67,60.32,9524000.0,10100000.0,5089.0,243174000.0,261968.0,,,,379000.0,110000.0,,,,,,,17500000.0,,23333914.0,,23333914.0,0.0,2000000.0,11000.0,-0.015,82000.0
